PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

222.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 241.50
  • 52 Week Low: 140.40
  • Currency: UK Pounds
  • Shares Issued: 270.41m
  • Volume: 88,108
  • Market Cap: £600.32m

PureTech Health's Vor wins FDA fast-track approval for cancer drug

By Frank Prenesti

Date: Friday 10 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
The US Food and Drug Administration granted the designation to VOR33, a hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukaemia.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 222.00p
Change Today -1.00p
% Change -0.45 %
52 Week High 241.50
52 Week Low 140.40
Volume 88,108
Shares Issued 270.41m
Market Cap £600.32m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.26% below the market average18.26% below the market average18.26% below the market average18.26% below the market average18.26% below the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
71.23% above the market average71.23% above the market average71.23% above the market average71.23% above the market average71.23% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average
Income Not Available
Growth
67.36% below the market average67.36% below the market average67.36% below the market average67.36% below the market average67.36% below the market average
76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
13:07 1,137 @ 222.00p
13:07 740 @ 222.00p
13:07 4 @ 222.50p
13:07 448 @ 222.50p
13:07 1,730 @ 222.50p

PRTC Key Personnel

CEO Bharatt Chowrira

Top of Page